Get Free Access
TZ Ref No.: TZ-1120651
Tender Notice Live Notice National (NCB) United States Healthcare and Medicine Pharmaceuticals Services

TRICARE Medicare Eligible Program Second Generation (TMEP2)

Doc ref no. HT940226R0001
Sector Healthcare and Medicine, Pharmaceuticals, Services
Publish Date 29 Sep 2026
Estimated Value Undisclosed
Tender Intelligence
Qualification analysis + key highlights for this procurement

TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.

A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.

Sign in to unlock Bid Fit & AI Opportunity Intelligence

TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).

Description & Project Overview

TRICARE Medicare Eligible Program Second Generation (TMEP2)
25 sep 2026: uploaded signed version of the basic rfp and amendment 0001 that updates the sensitivity labels of section j, attachment j-5b and exhibits l-7, l-8, l-9.
this acquisition is for the continuing requirement for health care claims processing, customer support and other associated administrative services (e.g. submission of tricare encounter data and provider certification) of dual-eligible medicare and tricare beneficiaries who receive medical services within the united states, puerto rico, guam, us virgin islands, american samoa, and northern mariana islands. usc title 10, chapter 55, and usc title 32, national defense, code of federal regulations (cfr) part 199, outline the benefit structure, administrative functions and the various health care programs, including tmep2.
this is a full and open competitive source selection, using best value trade-off procedures in accordance with rfo federal acquisition regulation (rfo far) 15.2, evaluation and award, as supplemented with defense far supplement and the dod source selection procedures (august 2022). the contract awarded will be a firm fixed-price contract. the contract will have a one 12-month base period of transiotion-in activiteis, seven 1-year periods for healthcare delivery, a one 12-month contract period for transition-out activities, and a potential 6-month extension of services permitted per rfo far clause 52.217-8, option to extend services, for a potential total period of performance of 8.5 years.

Days to Deadline
18 days
Closing: 05 Nov 2026, 00:00

Consortium & JV Partners

Matched
Need a Co-Bidder or Subcontractor?

Forming a Joint Venture increases technical eligibility and financial bonding capacity.

Post / Find JV Partners →

Key Procurement Details

Doc ref no. HT940226R0001
Notice Type Tender Notice
Bidding Type NCB
Publish Date 29 Sep 2026
Sector Healthcare and Medicine, Pharmaceuticals, Services
Document Fee Available in full notice
Bid Security Refer to documents
Funding Government Budget
Bid Opening Locked

Buyer Contact Information

Contact Details Locked

Nodal officer email, telephone, and website coordinates are unlocked upon free sign up.

Unlock Contact Details (Free) →